	Pattern of opioid prescriptions among patients with breast, lung, and colorectal cancer diagnosed with pre-existing chronic non-cancer pain. PLoS One Khadka S, Thornton JD, Kamal KM, Higa G, Kelly KM, Nduaguba SO. PMID: 42525681 [PubMed - in process]
	RE: Pembrolizumab with or without chemotherapy among older adults with advanced lung adenocarcinoma: a national, nonrandomized open-label phase 2 trial (Alliance A171901). J Natl Cancer Inst Zhang J, Yang H. PMID: 42525380 [PubMed - as supplied by publisher]
	Exploring the landscape of programmed cell death protein-1 and cluster of differentiation 28 positive T cells and cytokines in non-small cell lung cancer: A retrospective case-control study. J Int Med Res Yang Y, Li RC, Lyu C, Zhang W, Sun Y, Xie R. PMID: 42524709 [PubMed - in process]
	Integrative bulk and single-cell transcriptomic analysis identify an ac4C-related signature in lung adenocarcinoma. J Cancer Wang S, Yang C, Wang X, Zhu Z, Xie Y, Wang R, Liu D, Feng J. PMID: 42524437 [PubMed - in process]
	Ubiquitin-driven regulation of immune checkpoints in lung cancer: Mechanisms and therapeutic implications (Review). Exp Ther Med Chai L, Pang LR, Li YT, Wang JH, Chen J, Yuan ZG, Jin XF. PMID: 42524104 [PubMed - in process]
	Impact of hepatic radiotherapy on survival and safety outcomes in small cell lung cancer patients with liver metastases: a retrospective study. Ther Adv Med Oncol Liu X, Yu X, Wei Z, Wang X, Yu M, Cui W, Li Y, Yu J, Zhao K, Meng X. PMID: 42523939 [PubMed - in process]
	Immunotherapy and the novel therapeutic development for small-cell lung cancer. Ther Adv Med Oncol Matsuo M, Taniguchi H, Takemoto S, Mine K, Fukuda T, Hayashi F, Ono S, Akagi K, Tomono H, Honda N, Dotsu Y, Ashizawa K, Mukae H. PMID: 42523863 [PubMed]
	Predictive modeling for survival-related outcomes in lung cancer patients with brain metastases: a mini-review. Front Oncol Shorna SJ, Majumder S, Rahman D, Jahan F, Noori SRH, Hui LT, Nandi D, Rahman M. PMID: 42523629 [PubMed - in process]
	Treatment Patterns and Survival Outcomes in a Real-World Cohort of 263 Patients with EGFR L858R-Mutant Non-Small Cell Lung Cancer: Focus on EGFR-TKI Selection. Asian Pac J Cancer Prev Pham VH, Do HN, Nguyen KT, Ngo LV, Pham TH, Vo THA, Phan TT, Tran TTH, Tran TMH, Nguyen TTM, Le VT, Le THY, Tran TT, Truong KH. PMID: 42522829 [PubMed - indexed for MEDLINE]
	Predictive immunohistochemistry in non-small cell lung cancerÂ -Â Biomarkers, companion diagnostics, and molecular testing: A narrative review. Biomol Biomed Vrani, Rose I, Kuzmova N, Gatalica Z. PMID: 42522678 [PubMed - as supplied by publisher]
	Study of the Spectral-Luminescent Properties of Saliva in Patients With Lung Cancer. J Biophotonics Shakeyev KT, Zeinidenov AK, Aimukhanov AK, Alekseev AM, Kelgali GK, Zhumina AG, Sagyngali UK, Shestakov DV, Turgambekov GM, Mendibayeva AZ, Amangeldina AA. PMID: 42522547 [PubMed - indexed for MEDLINE]
	What are the symptom heterogeneity and network characteristics among lung cancer survivors in China? A cross-sectional latent profile and network analysis. BMJ Open Cao H, Wang X, Li Y, Zhang A, Ye S, Dang N, Tian C, Hao G, Cao J, Ma Q, Hou L. PMID: 42521301 [PubMed - indexed for MEDLINE]
	Development and Multi-center Validation of a Breathomics-Based Triage Tool for Lung Cancer: A Prospective Study of 5,214 Participants. Chest Qin J, Sun M, Li X, Duan X, Li Y, Ma H, Peng H, Jia W, Li G, Gu S, Zhao X, Cui F, Pei M, Sun D. PMID: 42521150 [PubMed - as supplied by publisher]
	Predicting end-of-treatment ventilation response to radiotherapy using early treatment ventilation for patients with lung cancer treated with photons and protons. Int J Radiat Oncol Biol Phys Lim R, O'Connor CS, Pan J, Tang TT, Castelo A, He Y, Titt U, Long JP, Altaie M, Mohan R, Liao Z, Brock KK. PMID: 42520860 [PubMed - as supplied by publisher]
	Validation of the lung immune prognostic index in extensive-stage small cell lung cancer: Post hoc analysis of the caspian and IMpower133 phase 3 trials. Eur J Cancer Auclin E, Roulleaux Dugage M, Gorría T, Laguna JC, Anguita D, Montes A, Rota M, Ferriol-Galmes M, Vauchier C, Lavaud P, Besse B, Mezquita L. PMID: 42520592 [PubMed - as supplied by publisher]
	Management of drug-induced interstitial lung disease in the era of evolving lung cancer therapies: A mini-review. Respir Investig Naraoka T, Sumi T. PMID: 42520532 [PubMed - as supplied by publisher]
	Lung cancer stem cells in the tumor microenvironment: translational biomarkers and therapeutic strategies for immune evasion and treatment resistance. Transl Oncol Shao LL, Shao JJ, Zhao TY, Cai ED, Wang Y, Lu RJ, Chen SH. PMID: 42520476 [PubMed - as supplied by publisher]
	Factors affecting lung cancer stage at diagnosis and receipt of surgery in Ontario: A population-based analysis. PLoS One Hanna NM, Shakeel S, Akhtar-Danesh GG, Akhtar-Danesh N, Finley C. PMID: 42520043 [PubMed - indexed for MEDLINE]
	Clinical application of urinary NTx in patients with bone metastases from lung cancer. J Bone Oncol Jiang L, Zhang P, Wang Z, Chang X, Lu P, Zhang Y, Sang G. PMID: 42519555 [PubMed]
	Biopsies Can Predict Lung Adenocarcinoma IASLC Grade: A New Proposal and Grading Pitfalls. JTO Clin Res Rep Zhou F, Basu A, Mantilla JG, Narula N, Moreira AL. PMID: 42519409 [PubMed]

Articles 1 - 20 / 161897

Page 1 of 8095



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy